When contacting your provider, be prepared to describe the timing of symptom onset relative to your semaglutide doses, the location and appearance of any skin changes, associated symptoms, and any new medications, supplements, or topical products you have started
The SHAPE study, analyzing real-world prescribing data, found: At 3 months: tirzepatide users lost 5.9% of body weight versus 3.6% for semaglutide At 6 months: 10.1% versus 5.8% At 12 months: 15.3% versus 8.3% These are averages from actual patients, not trial participants
For instance, does semaglutide affect your period
Does dong quai have estrogenic effects in postmenopausal women
Dosage guidance applies to US-sold Vicks DayQuil products and may differ from international versions
Atlas of genetic and phenotypic associations across 42 female reproductive health diagnoses